NEW 5-FU MODIFICATIONS IN COLORECTAL-CANCER

被引：0
|
作者：
EINHORN, LH [1 ]
机构：
[1] INDIANA UNIV,INDIANAPOLIS,IN 46223
来源：
CANCER INVESTIGATION | 1986年 / 4卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [31] FOLINIC ACID + 5-FLUOROURACIL (5-FU) VERSUS EQUIDOSE 5-FU IN ADVANCED COLORECTAL-CANCER - PHASE-III STUDY OF GISCAD (ITALIAN-GROUP-FOR-THE-STUDY-OF-DIGESTIVE-TRACT-CANCER)
    LABIANCA, R
    PANCERA, G
    AITINI, E
    BARNI, S
    BERETTA, A
    BERETTA, GD
    CESANA, B
    COMELLA, G
    COZZAGLIO, L
    CRISTONI, M
    SPAGNOLLI, P
    FRONTINI, L
    GOTTARDI, O
    MARTIGNONI, G
    SCAPATICCI, R
    SMERIERI, F
    VINCI, M
    ZADRO, A
    ZANIBONI, A
    LUPORINI, G
    ANNALS OF ONCOLOGY, 1991, 2 (09) : 673 - 679
  • [32] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
  • [33] Development of treatment for advanced colorectal cancer: Infusional 5-FU and the role of new agents
    Schmoll, HJ
    EUROPEAN JOURNAL OF CANCER, 1996, 32A : S18 - S22
  • [34] 5-FU related symptomatic cardiotoxicity in colorectal cancer patients: The impact of the new schedules
    Bencardino, K.
    Manzoni, M.
    Delfanti, S.
    Chatzileontiadou, S.
    Danova, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII70 - VII71
  • [35] 120-HOUR 5-FLUOROURACIL (5-FU) CONTINUOUS INFUSION (CI) PLUS BCNU IN ADVANCED COLORECTAL-CANCER
    VILLARGRIMALT, A
    CANDEL, MT
    DELGADO, F
    GARCIAREINOSO, J
    SANCHIS, C
    VICIANO, V
    ASENCIO, F
    MARTINEZABAD, M
    AGUILO, J
    SANCHEZ, JJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (05): : 387 - 392
  • [36] COMBINATION CHEMOTHERAPY CONTAINING SEMUSTINE (MECCNU) IN PATIENTS WITH ADVANCED COLORECTAL-CANCER PREVIOUSLY TREATED WITH 5-FLUOROURACIL (5-FU)
    ENGSTROM, PF
    MACINTYRE, JM
    DOUGLASS, HO
    MUGGIA, F
    MITTELMAN, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (02): : 175 - 180
  • [37] COMPARISON OF 5-FU VERSUS FUDR ACTIVITY IN HUMAN COLORECTAL-CANCER USING AN INVITRO CLONOGENIC-ASSAY (HTCA)
    FLENTJE, M
    FLENTJE, D
    SCHLAG, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (03) : 223 - 225
  • [38] PROTRACTED INFUSION OF 5-FU WITH WEEKLY LOW-DOSE CISPLATIN AS 2ND-LINE THERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER WHO HAVE FAILED 5-FU MONOTHERAPY
    AHLGREN, JD
    TROCKI, O
    GULLO, JJ
    GOLDBERG, R
    MUIR, WA
    SISK, R
    SCHACTER, L
    CANCER INVESTIGATION, 1991, 9 (01) : 27 - 33
  • [39] HIGH-DOSE LEUCOVORIN (CF), 5-FLUOROURACIL (5-FU) AND CISPLATIN (CIS) CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
    SCHEITHAUER, W
    DEPISCH, D
    SCHIESSEL, R
    ZIELINSKI, C
    PREIS, P
    GISSLINGER, H
    LUDWIG, H
    BLUT, 1988, 57 (04): : 206 - 206
  • [40] EARLY CLINICAL-TRIALS IN COLORECTAL-CANCER OF THE QUINONES COUMADIN AND VITAMIN-K COMBINED WITH 5-FLUOROURACIL (5-FU)
    BLOCK, JB
    CHLEBOWSKI, RT
    FEDERICO, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 138 - 138
12345